Kingman, ARIZONA5 Active Studies

Leukemia Clinical Trials in Kingman, ARIZONA

Find 5 actively recruiting leukemia clinical trials in Kingman, ARIZONA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
1,536
Enrolling

Recruiting Leukemia Studies in Kingman

RecruitingKingman, ARIZONANCT05624996

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by ...

474 participants
NRG Oncology
View Study Details
RecruitingKingman, ARIZONANCT04546399

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...

461 participants
National Cancer Institute (NCI)
View Study Details
RecruitingKingman, ARIZONANCT05602194

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

This phase III trial compares the effect of adding levocarnitine to standard chemotherapy versus (vs.) standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Aspara...

440 participants
Children's Oncology Group
View Study Details
RecruitingKingman, ARIZONANCT04205968

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work in treating patients with small bowel cance...

94 participants
SWOG Cancer Research Network
View Study Details
RecruitingKingman, ARIZONANCT04315324

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

This phase I/II trial studies the safety, side effects and best dose of OBI-3424 and how well it works in treating patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma th...

67 participants
SWOG Cancer Research Network
View Study Details

About Leukemia Clinical Trials in Kingman

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 5 leukemia clinical trials recruiting participants in Kingman, ARIZONA. These studies are seeking a combined 1,536 participants. Research is being sponsored by NRG Oncology, National Cancer Institute (NCI), Children's Oncology Group and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Kingman — FAQ

Are there leukemia clinical trials in Kingman?

Yes, there are 5 leukemia clinical trials currently recruiting in Kingman, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kingman?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kingman research site will contact you about next steps.

Are clinical trials in Kingman free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kingman studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 5 active trials in Kingman are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov